Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

Chipscreen's NDA for Novel Type 2 Diabetes Drug Accepted for China Review

publication date: Sep 20, 2019

Shenzhen Chipscreen Biosciences reported its new drug application for a first-in-class type 2 diabetes treatment was accepted for review in China. Chiglitazar, a novel small molecule peroxisome proliferator-activated receptor (PPAR) α/γ/δ pan-agonist, acts as an insulin sensitizer. The first PPAR pan-agonist to complete Phase III clinical trials, chiglitazar showed durable efficacy in glycemic control for patients with T2DM and metabolic syndrome. In August, Chipscreen completed a $147 million IPO on the Shanghai STAR board and rose 367% in its first trading day. More details....

Stock Symbol: (SHA: 688321)

Share this with colleagues:


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes


Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

ChinaBio® Events

 

China Showcase 2020

San Francisco, USA

January 12, 2020

ChinaBio Partnering Forum 2020

Suzhou, China

May 6-7, 2020

Other Events

CLINICAL DEVELOPMENT LEADERS' SUMMIT

Shanghai, China

November 12-14, 2019

 

CHINA HEALTHCARE SUMMIT 2019

Shanghai, China

November 18-20, 2019